Twist Bioscience

Last updated: October 09, 2024

Emily Leproust, CEO
Emily Leproust, CEO
USA | Funding: $553.1M (+)

Website: http://www.twistbioscience.com/

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development.